|
시장보고서
U.S. Breast Cancer Therapeutics Markets
|
Abstract
This research service explores the market for therapeutics used for the
treatment of breast cancer in the Unites States of America. It analyzes the
various challenges faced by pharmaceutical companies, and the competitive
advantages and disadvantages of their products in the market.
Table of Contents
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Breast Cancer Overview
- Disease Overview and Risk Factors
- Staging and Prognostic Factors
- Treatment Overview
- General Market Trends
- Competitive Structure
- Industry Challenges
- Market Drivers
- Market Restraints
3 PRODUCT AND PIPELINE ANALYSIS
- Approved Product Analysis
- Chemotherapy Product Analysis
- Hormonal Therapy Product Analysis
- Targeted Therapy Product Analysis
- Pipeline Analysis
- Chemotherapy Product Pipeline Analysis
- Hormonal Therapy Pipeline Analysis
- Targeted Therapy Pipeline Analysis
4 COMPETITIVE ANALYSIS
- Introduction
- Treatment Trends
- Market Engineering Measurements
- Common Drug Regimens
- Market Analysis
- Segment Market Share
- Targeted Therapy Forecasts
5 APPENDIX
- Decision Support Databases
- Breast Cancer Incidence Rates
- Breast Cancer Mortality Rates
- Total Female Population
- Physicians
- Total Population
|
